Ingmar Wolff

1.8k citations
64 papers · 1.2k · h-index 17

Impact in

Papers in

Ingmar Wolff

57 papers receiving 1.1k citations

Peers

Ingmar Wolff
Comparison fields: 5 of 100
  • Orthopedics and Sports Medicine 274
  • Pulmonary and Respiratory Medicine 258
  • Toxicology 27
  • Oncology 182
  • Cancer Research 94
Replace Sheryl L. Silfen with:
Sheryl L. Silfen United States
Richard Eastell United Kingdom
Samantha L. Bowker Canada
Kofi Asomaning United States
Hennie G. Raterman Netherlands
Dafang Zhang United States
Phillip Blanchette Canada
Sue Lynn Lau Australia
Pablo Ureña‐Torres France
Michelle McNabb United States
Ingmar Wolff relative to Sheryl L. Silfen United States Sheryl L. Silfen's profile →
Citations per field
00.5×5.4×
Sheryl L. Silfen · 1×
Citations per year

Countries citing papers authored by Ingmar Wolff

Since Specialization
Citations

This map shows the geographic impact of Ingmar Wolff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingmar Wolff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingmar Wolff more than expected).

Fields of papers citing papers by Ingmar Wolff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingmar Wolff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingmar Wolff. The network helps show where Ingmar Wolff may publish in the future.

Co-authors

The 25 scholars most cited alongside Ingmar Wolff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ingmar Wolff Line = papers co-authored together Ingmar Wolff links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1999435
2 199463
3 201353
4 202145
5 199645
6 201145
7 201243
8 200835
9 201134
10 200529
11 199428
12 201725
13 199523
14 200623
15
Phase I and pharmacological study of weekly administration of the polyamine synthesis inhibitor SAM 486A (CGP 48 664) in patients with solid tumors. European Organization for Research and Treatment of Cancer Early Clinical Studies Group.
200022
16 201021
17 201517
18
Phase I clinical and pharmacokinetic study of carzelesin (U-80244) given daily for five consecutive days.
199616
19 199315
20 201912

About Ingmar Wolff

Ingmar Wolff is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Public Health, Environmental and Occupational Health, having authored 64 papers that have together received 1.2k indexed citations. Recurring topics across this work include Genital Health and Disease (9 papers), Renal cell carcinoma treatment (7 papers), Bladder and Urothelial Cancer Treatments (7 papers), Prostate Cancer Diagnosis and Treatment (7 papers), Cancer Treatment and Pharmacology (5 papers), Renal and related cancers (4 papers), Epigenetics and DNA Methylation (4 papers) and Cancer therapeutics and mechanisms (3 papers). The work is most often cited by research in Orthopedics and Sports Medicine (274 citations), Pulmonary and Respiratory Medicine (258 citations), Toxicology (27 citations), Oncology (182 citations) and Cancer Research (94 citations). Ingmar Wolff has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Jos W. R. Twisk, Pieter J. Kostense, J.J. van Croonenborg, Han C. G. Kemper, Matthias May, Kurt Miller, J. Wanders, Steffen Weikert, Jaap Verweij and Steinar Aamdal. Their work appears in journals such as European Journal of Cancer, World Journal of Urology, PLoS ONE, Cancers and European Urology Focus.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact